Murphy B R, Chanock R M, Levine M M, van Blerk G A, Berquist E J, Douglas R G, Betts R F, Couch R B, Cate T R
Infect Immun. 1979 Feb;23(2):249-52. doi: 10.1128/iai.23.2.249-252.1979.
An influenza A virus recombinant bearing the surface antigens of the A/Victoria/3/75 (H3N2) strain and the two ts genes of the A/Udorn/72-ts-1A2 virus was evaluated for attenuation, antigenicity, and protective effect in 42 doubly seronegative adult volunteers (i.e., individuals who lacked detectable serum antibodies for the hemagglutinin and neuraminidase antigens). This recombinant, which had a 37 degrees C shutoff temperature for plaque formation and ts mutations on the genes thought to code for the P1 and P3 polymerase proteins, infected 90% of the volunteers. Of the volunteers, 5% developed mild coryza or rhinitis but other signs or symptoms were not observed, indicating that the A/Victoria/75-ts-1A2 recombinant was more attenuated than the A/Victoria/75-ts-1[E] recombinant. Vaccinees shed virus for a shorter interval and at a lower titer than did the A/Victoria/75-ts-1[E] vaccinees. Each ts-1A2 isolate retained the ts phenotype indicating that the recombinant was stable genetically in doubly seronegative adults. Finally, the ts-1A2 recombinant induced significant resistance to subsequent challenge with A/Victoria/75 wild-type virus.
对一种甲型流感病毒重组体进行了评估,该重组体携带A/维多利亚/3/75(H3N2)毒株的表面抗原以及A/乌冬/72-ts-1A2病毒的两个温度敏感(ts)基因,评估其在42名双血清阴性成年志愿者(即缺乏针对血凝素和神经氨酸酶抗原的可检测血清抗体的个体)中的减毒效果、抗原性和保护作用。这种重组体在37摄氏度时形成空斑的温度截止点为37摄氏度,并且在被认为编码P1和P3聚合酶蛋白的基因上存在ts突变,它感染了90%的志愿者。在这些志愿者中,5%出现了轻度鼻卡他或鼻炎,但未观察到其他体征或症状,这表明A/维多利亚/75-ts-1A2重组体比A/维多利亚/75-ts-1[E]重组体的减毒程度更高。接种疫苗者排出病毒的时间间隔更短,滴度也低于A/维多利亚/75-ts-1[E]疫苗接种者。每个ts-1A2分离株都保留了ts表型,这表明该重组体在双血清阴性成年人中基因稳定。最后,ts-1A2重组体诱导了对随后A/维多利亚/75野生型病毒攻击的显著抵抗力。